loader image
Friday, December 19, 2025
77.5 F
McAllen
- Advertisement -

Is Sucralose the Healthiest Sugar Substitute?

What the latest research says

Translate to Spanish or other 102 languages!

A study investigates whether sucralose is a safer alternative to gut health compared to sugar. Image for illustration purposes
A study investigates whether sucralose is a safer alternative to gut health compared to sugar. Image for illustration purposes

Medical News Today

- Advertisement -
  • The continual rise in obesity worldwide has reemphasized the need for healthier sugar substitutes. 
  • The past few years have seen various new sugar substitutes become available. 
  • Previous research shows some artificial sweeteners can potentially cause health issues. 
  • Researchers from the University of Vienna found that consuming the artificial sweetener sucralose did not cause an increase in bacterial endotoxin levels in the body, compared to consuming sugar. 

A new study in Austria examined how artificial sweetener sucralose impacts our gut health and found that it may be a safer alternative to consuming sugar.

Follow he link below to Medical News Tday to read the entire article:

https://www.medicalnewstoday.com/articles/is-sucralose-healthiest-sugar-substitute-latest-research-gut-health

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.

Early Findings Show Breast Cancer Vaccine Produces Immune Response

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine. 
- Advertisement -
×